Stay updated on Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now displays a new system revision label (v3.4.2) and removes older notices (v3.4.1). This update appears to be a UI/system change and does not modify study data or visible content.
    Difference
    0.4%
    Check dated 2026-02-11T02:32:52.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status was added, and the page revision was updated to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T01:42:01.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a Show glossary link and new results-status fields (Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted) while removing older timestamps and the No FEAR Act data field, and updated the revision from v3.3.4 to v3.4.0.
    Difference
    0.3%
    Check dated 2026-01-27T23:38:37.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Page revision label updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-14T01:50:06.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Removed the HHS Vulnerability Disclosure link from the page footer and updated the revision label to Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T17:13:23.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Results have been posted and a results section added, including primary and secondary outcomes (ORR at 6 months, non-progression at 6 months, PFS, OS) with specified timeframes. Links to the Study Protocol and Statistical Analysis Plan are now available, and study results timing (Results First Posted/Submitted) has been updated.
    Difference
    8%
    Check dated 2025-12-16T03:48:21.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page.